Use of CYP3Ai and impact on outcomes in patients with acute myeloid leukemia treated with venetoclax plus azacitidine in the VIALE-A study.
Brian A JonasCourtney D D DiNardoNicola Stefano FracchiollaAlexander PristupaKenichi IshizawaJie JinMarina Y KonoplevaYishai OfranPau MontesinosTibor KovacsovicsJun-Ho JangHagop M KantarjianYinghui DuanJalaja PotluriMichael WernerKeith W PratzPublished in: American journal of hematology (2022)